Abstract: The present invention relates to a method for preparing stem cells having a size suitable for intravascular administration, and preferably to a method for preparing stem cells with a diameter ranging from 11-16 ?m. Additionally, the present invention relates to media composition for preparing stem cells having a size suitable for intravascular administration. According to the present invention, stem cells having a size suitable for intravascular administration can be prepared such that stem cells administered into a vein can stably reach a target tissue, and thus can more efficiently increase efficacy displaying activity, thereby innovatively enhancing the efficacy of cell therapy using stem cells.
Type:
Application
Filed:
October 26, 2020
Publication date:
February 11, 2021
Applicants:
K-STEMCELL CO., LTD
Inventors:
Jeong Chan RA, Sung Keun KANG, Il Seob SHIN
Abstract: The present invention relates to a method for preparing stem cells having a size suitable for intravascular administration, and preferably to a method for preparing stem cells with a diameter ranging from 11-16 ?m. Additionally, the present invention relates to media composition for preparing stem cells having a size suitable for intravascular administration. According to the present invention, stem cells having a size suitable for intravascular administration can be prepared such that stem cells administered into a vein can stably reach a target tissue, and thus can more efficiently increase efficacy displaying activity, thereby innovatively enhancing the efficacy of cell therapy using stem cells.
Type:
Grant
Filed:
April 17, 2013
Date of Patent:
October 27, 2020
Assignees:
K-STEMCELL CO., LTD.
Inventors:
Jeong Chan Ra, Sung Keun Kang, Il Seob Shin
Abstract: The present invention relates to a method for preparing stem cells in high concentration. The present invention makes it possible to grow stem cells in an amount sufficient to be clinically usable in a short time, and makes it possible to relatively efficiently enhance the ability of administered stem cells to efficaciously reach target tissue and exhibit an action in a stable fashion and can therefore dramatically increase the efficacy of cell therapy using stem cells.
Type:
Application
Filed:
May 23, 2013
Publication date:
April 30, 2015
Applicants:
K-STEMCELL CO., LTD.
Inventors:
Jeong Chan Ra, Sung Keun Kang, Jung Youn Jo
Abstract: There is provided a method for preventing disruption and aggregation of stem cells. In addition, there is provided a stem cell composition for intravascular administration, in which stem cells are suspended in a solution containing aspirin. Further, there is provided a composition for preventing disruption or aggregation of stem cells, in which stem cells are suspended in a solution containing aspirin. According to the present invention, disruption and aggregation of cells may be prevented during transport or storage, such that the administered stem cells may stably reach the target tissue and exhibit the activity thereof in a more efficient manner, thereby remarkably increasing the effect of cell therapy using stem cells.
Type:
Application
Filed:
April 15, 2013
Publication date:
April 30, 2015
Applicants:
K-STEMCELL CO., LTD.
Inventors:
Jeong Chan Ra, Sung Keun Kang, Il Seob Shin
Abstract: The present invention relates to a method for preparing stem cells having a size suitable for intravascular administration, and preferably to a method for preparing stem cells with a diameter ranging from 11-16 ?m. Additionally, the present invention relates to media composition for preparing stem cells having a size suitable for intravascular administration. According to the present invention, stem cells having a size suitable for intravascular administration can be prepared such that stem cells administered into a vein can stably reach a target tissue, and thus can more efficiently increase efficacy displaying activity, thereby innovatively enhancing the efficacy of cell therapy using stem cells.
Type:
Application
Filed:
April 17, 2013
Publication date:
March 12, 2015
Applicants:
K-STEMCELL CO., LTD.
Inventors:
Jeong Chan Ra, Sung Keun Kang, Il Seob Shin